DR Congo receives first batch of Ebola vaccine amid exponential virus spread

The Democratic Republic of the Congo (DRC) has received its first shipment of over 16,000 doses of the Ervebo vaccine, a crucial step in combating the nation's deadliest Ebola outbreak. This delivery is part of a commitment by the World Health Organization (WHO) and its partners to provide 70,000 doses to the capital, Kinshasa, with more expected next week.

This influx of vaccines comes amid dire warnings from experts about the exponential spread of the virus. The outbreak has claimed more than 2,500 lives out of nearly 5,300 confirmed cases. The UN has cautioned that infections are continuing to surge, and data suggests transmission has not yet peaked, potentially reaching three times its current rate.

While Ervebo is approved for the Zaire strain of Ebola, the Bundibugyo strain currently circulating in the DRC does not have an approved vaccine or treatment. However, early animal trial data indicates it might offer some protection, according to the WHO. The DRC's health minister, Samuel Roger Kamba, noted that Ervebo has been used effectively in previous outbreaks.

Of the 70,000 doses allocated to the DRC, 20,000 will be used in a late-stage clinical trial to assess their efficacy against the Bundibugyo strain. The remaining doses are designated for front-line health workers. Efforts to contain the virus face significant hurdles, including ongoing armed conflict, delays in identifying cases, and inadequate infrastructure in eastern DRC, complicating containment strategies.

“

on a very large scale